Methotrexate toxicity-response

Affiliations

¹ Department of Medicine A, The Chaim Sheba Medical Center, Ramat-Gan, Israel; The Dr. Pinchas Borenstein Talpiot Medical Leadership Program 2013, The Chaim Sheba Medical Center, Ramat-Gan, Israel; The Zabludovicz Center for Autoimmune Diseases, The Chaim Sheba Medical Center, Ramat-Gan, Israel; Sackler School of Medicine, Ramat-Aviv, Israel. Electronic address: kivitys@gmail.com.
² The Zabludovicz Center for Autoimmune Diseases, The Chaim Sheba Medical Center, Ramat-Gan, Israel.
³ the Institute of Clinical Pharmacology & Toxicology, The Chaim Sheba Medical Center, Ramat-Gan, Israel; Sackler School of Medicine, Ramat-Aviv, Israel.
⁴ Department of Medicine E, The Chaim Sheba Medical Center, Ramat-Gan, Israel; Sackler School of Medicine, Ramat-Aviv, Israel.

Comment

Shaye Kivity et al. Autoimmun Rev. 2016 Dec.

. 2016 Dec;15(12):1199.

doi: 10.1016/j.autrev.2016.04.007. Epub 2016 Apr 19.

¹ Department of Medicine A, The Chaim Sheba Medical Center, Ramat-Gan, Israel; The Dr. Pinchas Borenstein Talpiot Medical Leadership Program 2013, The Chaim Sheba Medical Center, Ramat-Gan, Israel; The Zabludovicz Center for Autoimmune Diseases, The Chaim Sheba Medical Center, Ramat-Gan, Israel; Sackler School of Medicine, Ramat-Aviv, Israel. Electronic address: kivitys@gmail.com.
² The Zabludovicz Center for Autoimmune Diseases, The Chaim Sheba Medical Center, Ramat-Gan, Israel.
³ the Institute of Clinical Pharmacology & Toxicology, The Chaim Sheba Medical Center, Ramat-Gan, Israel; Sackler School of Medicine, Ramat-Aviv, Israel.
⁴ Department of Medicine E, The Chaim Sheba Medical Center, Ramat-Gan, Israel; Sackler School of Medicine, Ramat-Aviv, Israel.

No abstract available

Comment on

Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.
Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H. Kivity S, et al. Autoimmun Rev. 2014 Nov;13(11):1109-13. doi: 10.1016/j.autrev.2014.08.027. Epub 2014 Aug 27. Autoimmun Rev. 2014. PMID: 25172240 Review.
Letter to the editor in response to the article "Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients" by Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H, Autoimmun Rev. 2014 Nov.;13(11):1109-13: Height of MTX-PG levels in low-dose MTX-toxicity differs according to the time of onset.
Wassenaar S, den Boer E, Westerman EM, Hazes JM, de Jonge R. Wassenaar S, et al. Autoimmun Rev. 2016 Nov;15(11):1109-1110. doi: 10.1016/j.autrev.2016.04.006. Epub 2016 Apr 16. Autoimmun Rev. 2016. PMID: 27095131 No abstract available.